Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antiphospholipid Antibodies and Syndrome / / edited by Ricard Cervera
| Antiphospholipid Antibodies and Syndrome / / edited by Ricard Cervera |
| Pubbl/distr/stampa | Basel : , : MDPI, , 2018 |
| Descrizione fisica | 1 online resource (vii, 125 pages) : illustrations |
| Disciplina | 616.978 |
| Soggetto topico | Antiphospholipid syndrome |
| ISBN | 3-03842-948-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910765774603321 |
| Basel : , : MDPI, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiphospholipid syndrome : recent advances in clinical and basic aspects / / edited by Polona Žigon
| Antiphospholipid syndrome : recent advances in clinical and basic aspects / / edited by Polona Žigon |
| Pubbl/distr/stampa | London, England : , : IntechOpen, , [2022] |
| Descrizione fisica | 1 online resource (142 pages) |
| Disciplina | 616.978 |
| Soggetto topico |
Antiphospholipid syndrome
Immunologic diseases Phospholipid antibodies |
| ISBN | 1-83969-054-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Antiphospholipid Syndrome |
| Record Nr. | UNINA-9910586648303321 |
| London, England : , : IntechOpen, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiphospholipid syndrome / / edited by Alena Bulikova
| Antiphospholipid syndrome / / edited by Alena Bulikova |
| Pubbl/distr/stampa | Rijeka, Croatia : , : InTech, , [2012] |
| Descrizione fisica | 1 online resource (244 pages) |
| Disciplina | 616.978 |
| Soggetto topico | Antiphospholipid syndrome |
| ISBN | 953-51-6970-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910138349103321 |
| Rijeka, Croatia : , : InTech, , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiphospholipid syndrome in systemic autoimmune diseases / / edited by Ricardo Cubedo Cervera, Gerard Espinosa, Munther Khamashta
| Antiphospholipid syndrome in systemic autoimmune diseases / / edited by Ricardo Cubedo Cervera, Gerard Espinosa, Munther Khamashta |
| Pubbl/distr/stampa | Amsterdam, Netherlands : , : Elsevier, , 2016 |
| Descrizione fisica | 1 online resource (328 pages) : illustrations, tables |
| Disciplina | 616.978 |
| Collana | Handbook of Systemic Autoimmune Diseases |
| Soggetto topico | Antiphospholipid syndrome |
| ISBN | 0-444-63656-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583311603321 |
| Amsterdam, Netherlands : , : Elsevier, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden
| Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2003 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina |
571.9/73
616.97/8 616.978 |
| Altri autori (Persone) |
HerrmannM, Dr. (Martin)
KaldenJ. R (Joachim Robert) |
| Soggetto topico |
Apoptosis
Autoimmunity Autoimmune diseases |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-52038-8
9786610520381 3-527-60529-0 3-527-60145-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Apoptosis and Autoimmunity; Preface; Contents; List of Contributors; Part 1 General Features of Apoptosis; 1 Apoptosis and Autoimmunity; 1.1 Introduction; 1.2 Autoimmune Diseases Associated with Targeted Cell Destruction; 1.2.1 What is the Mode of Cell Death?; 1.2.2 What Cells and What Effector Pathways are Responsible for Cell Death?; 1.3 Autoimmune Diseases Associated with Enhanced Cell Growth and Survival; 1.4 Autoimmune Diseases Associated with Abnormal Processing of Dying Cells; 1.5 Conclusions; 1.6 References; 2 Caspase Knockouts: Matters of Life and Death
2.1 Death, Development and Immune Function2.2 Apoptotic Pathways: from Nematode to Mammals; 2.3 Triggering a Killer: General Aspects of Caspase Activation; 2.4 Caspase-1 and -11: More than Mediators of Inflammatory Cytokines?; 2.5 Caspase-8 and the FAS Signaling Pathway; 2.6 Caspase-3: The Chief Executioner?; 2.7 Caspase-9: Mitochondrial Activation and the Apoptosome; 2.8 Caspase-2: A Duality of Function; 2.9 Caspase-12: Responding to Stress; 2.10 Compensatory Caspase Activation: A Caveat to Knockout Analysis; 2.11 Caspases: More than Simple Killers; 2.12 Concluding Remarks; 2.13 References Part 2 Clearance of Apoptotic Cells3 Anti-inflammatory and Immunoregulatory Effects of Apoptotic Cells; 3.1 Introduction; 3.2 Anti-inflammatory Effects of Apoptotic Cells on Monocytes/Macrophages; 3.3 The Role of Anti-inflammatory Cytokines for the Inhibition of Pro-inflammatory Cytokine Production; 3.4 Monocyte/Macrophage Receptors receiving the Anti-inflammatory Signal from Apoptotic Cells; 3.5 Intracellular Signaling Events Causing the Anti-inflammatory State in Macrophages; 3.6 Apoptotic Cells Impair MHC Class II Surface Expression on Monocytes 3.7 Influence of Apoptotic Cells on DC Function in Allogeneic MLR3.8 The Presence of Apoptotic Cells can Shift the T(h) Cell Response towards T(h)2; 3.9 Apoptotic Cells Suppress Delayed-type Hypersensitivity (DTH) In Vivo; 3.10 Necrosis and Inflammation; 3.11 Implications of the Anti-inflammatory and Immunodulatory Effects of Apoptotic Cells for Health and Disease; 3.11.1 Apoptosis and Pregnancy; 3.11.2 Apoptosis and Irradiation; 3.11.3 Apoptosis and Cancer; 3.11.4 Apoptosis and Infections; 3.11.5 Apoptosis and Blood Transfusions; 3.12 References; 4 Complement and Apoptosis; 4.1 Introduction 4.2 Programmed Cell Death (PCD)4.3 Complement; 4.4 Complement and Apoptosis; 4.4.1 Role of Complement in the Execution Phase; 4.4.2 Complement Activation by Apoptotic Cells; 4.5 Apoptosis, Complement and Autoimmunity; 4.6 References; 5 Soluble Factors that Bind to Dying Cells Control the Outcome of Corpse Disposal: The Role of Pentraxins, Collectins and Autoantibodies; 5.1 Introduction; 5.2 Soluble Factors Involved in Apoptotic Cell Recognition and Internalization; 5.2.1 Corpse Clearance at Rest: Collectins; 5.2.2 Corpse Clearance at Rest: Cationic Factors and Other PS-binding Moieties 5.2.3 Corpse Clearance during Acute Inflammation: Pentraxins |
| Record Nr. | UNINA-9910146242903321 |
| Weinheim, : Wiley-VCH, c2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden
| Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2003 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina |
571.9/73
616.97/8 616.978 |
| Altri autori (Persone) |
HerrmannM, Dr. (Martin)
KaldenJ. R (Joachim Robert) |
| Soggetto topico |
Apoptosis
Autoimmunity Autoimmune diseases |
| ISBN |
1-280-52038-8
9786610520381 3-527-60529-0 3-527-60145-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Apoptosis and Autoimmunity; Preface; Contents; List of Contributors; Part 1 General Features of Apoptosis; 1 Apoptosis and Autoimmunity; 1.1 Introduction; 1.2 Autoimmune Diseases Associated with Targeted Cell Destruction; 1.2.1 What is the Mode of Cell Death?; 1.2.2 What Cells and What Effector Pathways are Responsible for Cell Death?; 1.3 Autoimmune Diseases Associated with Enhanced Cell Growth and Survival; 1.4 Autoimmune Diseases Associated with Abnormal Processing of Dying Cells; 1.5 Conclusions; 1.6 References; 2 Caspase Knockouts: Matters of Life and Death
2.1 Death, Development and Immune Function2.2 Apoptotic Pathways: from Nematode to Mammals; 2.3 Triggering a Killer: General Aspects of Caspase Activation; 2.4 Caspase-1 and -11: More than Mediators of Inflammatory Cytokines?; 2.5 Caspase-8 and the FAS Signaling Pathway; 2.6 Caspase-3: The Chief Executioner?; 2.7 Caspase-9: Mitochondrial Activation and the Apoptosome; 2.8 Caspase-2: A Duality of Function; 2.9 Caspase-12: Responding to Stress; 2.10 Compensatory Caspase Activation: A Caveat to Knockout Analysis; 2.11 Caspases: More than Simple Killers; 2.12 Concluding Remarks; 2.13 References Part 2 Clearance of Apoptotic Cells3 Anti-inflammatory and Immunoregulatory Effects of Apoptotic Cells; 3.1 Introduction; 3.2 Anti-inflammatory Effects of Apoptotic Cells on Monocytes/Macrophages; 3.3 The Role of Anti-inflammatory Cytokines for the Inhibition of Pro-inflammatory Cytokine Production; 3.4 Monocyte/Macrophage Receptors receiving the Anti-inflammatory Signal from Apoptotic Cells; 3.5 Intracellular Signaling Events Causing the Anti-inflammatory State in Macrophages; 3.6 Apoptotic Cells Impair MHC Class II Surface Expression on Monocytes 3.7 Influence of Apoptotic Cells on DC Function in Allogeneic MLR3.8 The Presence of Apoptotic Cells can Shift the T(h) Cell Response towards T(h)2; 3.9 Apoptotic Cells Suppress Delayed-type Hypersensitivity (DTH) In Vivo; 3.10 Necrosis and Inflammation; 3.11 Implications of the Anti-inflammatory and Immunodulatory Effects of Apoptotic Cells for Health and Disease; 3.11.1 Apoptosis and Pregnancy; 3.11.2 Apoptosis and Irradiation; 3.11.3 Apoptosis and Cancer; 3.11.4 Apoptosis and Infections; 3.11.5 Apoptosis and Blood Transfusions; 3.12 References; 4 Complement and Apoptosis; 4.1 Introduction 4.2 Programmed Cell Death (PCD)4.3 Complement; 4.4 Complement and Apoptosis; 4.4.1 Role of Complement in the Execution Phase; 4.4.2 Complement Activation by Apoptotic Cells; 4.5 Apoptosis, Complement and Autoimmunity; 4.6 References; 5 Soluble Factors that Bind to Dying Cells Control the Outcome of Corpse Disposal: The Role of Pentraxins, Collectins and Autoantibodies; 5.1 Introduction; 5.2 Soluble Factors Involved in Apoptotic Cell Recognition and Internalization; 5.2.1 Corpse Clearance at Rest: Collectins; 5.2.2 Corpse Clearance at Rest: Cationic Factors and Other PS-binding Moieties 5.2.3 Corpse Clearance during Acute Inflammation: Pentraxins |
| Record Nr. | UNINA-9910830049703321 |
| Weinheim, : Wiley-VCH, c2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Apoptosis and autoimmunity / / edited by M. Hermann and J.R. Kalden
| Apoptosis and autoimmunity / / edited by M. Hermann and J.R. Kalden |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2003 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina |
571.9/73
616.97/8 616.978 |
| Altri autori (Persone) |
HerrmannM, Dr. (Martin)
KaldenJ. R (Joachim Robert) |
| Soggetto topico |
Apoptosis
Autoimmunity Autoimmune diseases |
| ISBN |
1-280-52038-8
9786610520381 3-527-60529-0 3-527-60145-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Apoptosis and Autoimmunity; Preface; Contents; List of Contributors; Part 1 General Features of Apoptosis; 1 Apoptosis and Autoimmunity; 1.1 Introduction; 1.2 Autoimmune Diseases Associated with Targeted Cell Destruction; 1.2.1 What is the Mode of Cell Death?; 1.2.2 What Cells and What Effector Pathways are Responsible for Cell Death?; 1.3 Autoimmune Diseases Associated with Enhanced Cell Growth and Survival; 1.4 Autoimmune Diseases Associated with Abnormal Processing of Dying Cells; 1.5 Conclusions; 1.6 References; 2 Caspase Knockouts: Matters of Life and Death
2.1 Death, Development and Immune Function2.2 Apoptotic Pathways: from Nematode to Mammals; 2.3 Triggering a Killer: General Aspects of Caspase Activation; 2.4 Caspase-1 and -11: More than Mediators of Inflammatory Cytokines?; 2.5 Caspase-8 and the FAS Signaling Pathway; 2.6 Caspase-3: The Chief Executioner?; 2.7 Caspase-9: Mitochondrial Activation and the Apoptosome; 2.8 Caspase-2: A Duality of Function; 2.9 Caspase-12: Responding to Stress; 2.10 Compensatory Caspase Activation: A Caveat to Knockout Analysis; 2.11 Caspases: More than Simple Killers; 2.12 Concluding Remarks; 2.13 References Part 2 Clearance of Apoptotic Cells3 Anti-inflammatory and Immunoregulatory Effects of Apoptotic Cells; 3.1 Introduction; 3.2 Anti-inflammatory Effects of Apoptotic Cells on Monocytes/Macrophages; 3.3 The Role of Anti-inflammatory Cytokines for the Inhibition of Pro-inflammatory Cytokine Production; 3.4 Monocyte/Macrophage Receptors receiving the Anti-inflammatory Signal from Apoptotic Cells; 3.5 Intracellular Signaling Events Causing the Anti-inflammatory State in Macrophages; 3.6 Apoptotic Cells Impair MHC Class II Surface Expression on Monocytes 3.7 Influence of Apoptotic Cells on DC Function in Allogeneic MLR3.8 The Presence of Apoptotic Cells can Shift the T(h) Cell Response towards T(h)2; 3.9 Apoptotic Cells Suppress Delayed-type Hypersensitivity (DTH) In Vivo; 3.10 Necrosis and Inflammation; 3.11 Implications of the Anti-inflammatory and Immunodulatory Effects of Apoptotic Cells for Health and Disease; 3.11.1 Apoptosis and Pregnancy; 3.11.2 Apoptosis and Irradiation; 3.11.3 Apoptosis and Cancer; 3.11.4 Apoptosis and Infections; 3.11.5 Apoptosis and Blood Transfusions; 3.12 References; 4 Complement and Apoptosis; 4.1 Introduction 4.2 Programmed Cell Death (PCD)4.3 Complement; 4.4 Complement and Apoptosis; 4.4.1 Role of Complement in the Execution Phase; 4.4.2 Complement Activation by Apoptotic Cells; 4.5 Apoptosis, Complement and Autoimmunity; 4.6 References; 5 Soluble Factors that Bind to Dying Cells Control the Outcome of Corpse Disposal: The Role of Pentraxins, Collectins and Autoantibodies; 5.1 Introduction; 5.2 Soluble Factors Involved in Apoptotic Cell Recognition and Internalization; 5.2.1 Corpse Clearance at Rest: Collectins; 5.2.2 Corpse Clearance at Rest: Cationic Factors and Other PS-binding Moieties 5.2.3 Corpse Clearance during Acute Inflammation: Pentraxins |
| Record Nr. | UNINA-9910841657903321 |
| Weinheim, : Wiley-VCH, c2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs / / Ronald A. Booth [and seventeen others]
| Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs / / Ronald A. Booth [and seventeen others] |
| Autore | Booth Ronald A. |
| Pubbl/distr/stampa | Rockville, Maryland : , : Agency for Healthcare Research and Quality (US), , [2010] |
| Descrizione fisica | 1 online resource (288 pages) : illustrations |
| Disciplina | 616.978 |
| Altri autori (Persone) |
MoherDavid <1957->
BoothRonald A |
| Collana | Evidence Reports/Technology Assessments |
| Soggetto topico | Autoimmune diseases |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910703041403321 |
Booth Ronald A.
|
||
| Rockville, Maryland : , : Agency for Healthcare Research and Quality (US), , [2010] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autoantibodies / / edited by Yehuda Shoenfeld M.D., FRCP, MACR, Professor of Rheumatology, Head, Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni M.D., Professor of Rheumatology Department of Clinical Sciences and Community Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA
| Autoantibodies / / edited by Yehuda Shoenfeld M.D., FRCP, MACR, Professor of Rheumatology, Head, Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni M.D., Professor of Rheumatology Department of Clinical Sciences and Community Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Waltham, MA : , : Elsevier, , 2014 |
| Descrizione fisica | 1 online resource (lx, 855 pages) : illustrations (some color) |
| Disciplina | 616.978 |
| Altri autori (Persone) |
ShoenfeldYehuda
MeroniPier-Luigi GershwinM. Eric <1946-> |
| Collana | Elsevier science & technology books |
| Soggetto topico |
Autoantibodies
Autoimmune diseases - Etiology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-444-59377-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | part 1. Introduction : autoantibodies-unique characteristics -- part 2. Allergic disease autoantibodies -- part 3. Antineutrophil antibodies -- part 4. Introduction : antinuclear antibodies -- part 5. Autoantibodies to biologic factors/structures -- part 6. Cardiac autoantibodies -- part 7. Endocrine autoantibodies -- part 8. GI and liver autoantibodies -- part 9. Hematologic autoantibodies -- part 10. Kidney autoantibodies -- part 11. Neurological system autoantibodies -- part 12. Rheumatic disease autoantibodies -- part 13. Skin disease autoantibodies -- part 14. Unique clinical situations. |
| Record Nr. | UNINA-9910453291703321 |
| Waltham, MA : , : Elsevier, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autoantibodies / / edited by Yehuda Shoenfeld, M.D., FRCP, MACR, Professor of Rheumatology, Head: Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni, M.D., Professor of Rheumatology, Department of Clinical Sciences and Community, Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin, M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA
| Autoantibodies / / edited by Yehuda Shoenfeld, M.D., FRCP, MACR, Professor of Rheumatology, Head: Zabludowicz Center for Autoimmune Diseases, Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel, Pier Luigi Meroni, M.D., Professor of Rheumatology, Department of Clinical Sciences and Community, Health - University of Milan, Chief, Division of Rheumatology, Istituto G. Pini, Milan, Italy, M. Eric Gershwin, M.D., MACP, MACR, Distinguished Professor of Medicine, The Jack and Donald Chia Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, USA |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Waltham, MA : , : Elsevier, , 2014 |
| Descrizione fisica | 1 online resource (lx, 855 pages) : illustrations (some color) |
| Disciplina | 616.978 |
| Collana |
Gale eBooks
Elsevier science & technology books |
| Soggetto topico | Autoantibodies |
| ISBN | 0-444-59377-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | part 1. Introduction : autoantibodies-unique characteristics -- part 2. Allergic disease autoantibodies -- part 3. Antineutrophil antibodies -- part 4. Introduction : antinuclear antibodies -- part 5. Autoantibodies to biologic factors/structures -- part 6. Cardiac autoantibodies -- part 7. Endocrine autoantibodies -- part 8. GI and liver autoantibodies -- part 9. Hematologic autoantibodies -- part 10. Kidney autoantibodies -- part 11. Neurological system autoantibodies -- part 12. Rheumatic disease autoantibodies -- part 13. Skin disease autoantibodies -- part 14. Unique clinical situations. |
| Record Nr. | UNINA-9910790757303321 |
| Waltham, MA : , : Elsevier, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
